RECYTE THERAPEUTICS

recyte-therapeutics-logo

BioTime, Inc. (NYSE Amex: BTX) is a biotechnology company developing products in the emerging field of regenerative medicine using stem cell technology. The Company has isolated over 140 diverse, scalable, and proprietary progenitors to the cell types in the human body. The numerous uses of these cells to regenerate tissue function are being developed through disease-focused subsidiaries of BioTime. ReCyte Therapeutics is one such subsidiary focused on applying the Company's proprietary ReCyteรข... โ€žยข technology to blood and vascular aging. ReCyteรขโ€žยข is a technology capable of reprogramming cells taken from aged patients back to an embryonic state such that all cell types can be produced genetically identical to the patient. It is also capable of resetting the telomere clock of cellular aging to make any type of young cells otherwise identical to aged patients. ReCyte's mission is to pioneer the application of this advance in gerontology to the largest unmet need in aging; namely cardiovascular and blood senescence.

#People #Website #More

RECYTE THERAPEUTICS

Industry:
Biotechnology Medical Pharmaceutical

Founded:
2007-01-01

Address:
Alameda, California, United States

Country:
United States

Website Url:
http://www.recyte.com

Total Employee:
1+

Status:
Closed

Contact:
510-521-3390

Email Addresses:
[email protected]

Total Funding:
9.9 M USD

Technology used in webpage:
Google Maps Google Google Cloud Amazon Route 53 Pound Sterling Japanese Yen Google Cloud South Carolina


Current Employees Featured

michael-d-west_image

Michael D West
Michael D West CEO @ ReCyte Therapeutics
CEO

not_available_image

Judith Segall
Judith Segall Corporate Secretary @ ReCyte Therapeutics
Corporate Secretary

Official Site Inspections

http://www.recyte.com

Unable to get host informations!!!

Loading ...

More informations about "ReCyte Therapeutics" on Search Engine